RE:RE:PP this summer after major media event????
The company has been in discussions on CarT for the last 2 years. From this cc.....
One final note, we continue to advance our preclinical CAR-T program in ongoing discussions with multiple potential biopharma and research partners and maintain constructive conversations on a potential clinical trial.
There is no way to tell how close they are to signing at this time.